US Pharmacovigilance Market to Witness an Impressive CAGR until 2025
Increasing rate of drug development and rising cases of adverse drug reactions to drive United States pharmacovigilance market According to TechSci Research report, “United States Pharmacovigilance Market By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service… Read More »